Skip to Navigation Skip to Search Skip to Content
Search All Centers

Current Treatment Options for Metastatic, Castrate-Resistant Prostate Cancer

View next

Published on October 28, 2014

Dr. Neal Shore, a noted prostate cancer researcher, explores what is available today for men with metastatic, castrate-resistant prostate cancer(mCRPC). Dr. Shore explains why he feels, after new medicines no longer work, patients should not fear chemotherapy.

This content was provided by the Patient Empowerment Network, which received an unrestricted educational grant from Bayer Oncology.

Featuring

Sponsors

Patient Empowerment Network
View next